Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Access to the study record now displays a 403 Forbidden page, replacing the usual study details and navigation. The change prevents viewing the study content on this page.
    Difference
    18%
    Check dated 2026-09-19T20:36:25.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.6, signaling an underlying update to the page. No study content or user-facing elements appear to be altered.
    Difference
    0.0%
    Check dated 2026-08-29T20:02:51.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5, replacing the previous v3.6.4. This indicates an updated version of the page's revision history.
    Difference
    0.0%
    Check dated 2026-08-08T23:28:02.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the page. No study details or user-facing content were changed.
    Difference
    0.0%
    Check dated 2026-07-25T16:56:06.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    New resources and documents have been added to the trial page, including a PDF of the Study Protocol and Statistical Analysis Plan provided by Bristol-Myers Squibb, and sponsor sections for clinical trial recruitment and information. The page also includes a Publications section and expanded keywords, improving access to official materials and related literature.
    Difference
    100%
    Check dated 2026-07-04T08:20:48.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.6.2 is now shown on the page. Several sponsor- and document-related footer items were removed, which changes how study documents and sponsor context are accessed while leaving the core trial details unchanged.
    Difference
    16%
    Check dated 2026-06-27T04:13:53.000Z thumbnail image

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.